ANDA 88290, held by Abraxis Pharm. Nandrolone Decanoate.
As of Nov 15, 2026, ANDA 88290 (Nandrolone Decanoate), held by Abraxis Pharm, was not approved, with 2 approved supplements and 0 published complete response letters.
| Product | Active ingredient | Marketing |
|---|---|---|
| Nandrolone Decanoate100MG/ML ยท injectable;injection | Nandrolone Decanoate | Discontinued |
| Feb 4, 1991 | Supplement 12Labeling | Approved | None posted |
| Mar 17, 1989 | Supplement 7Labeling | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters
